A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
Clinical trial NCT05393804 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05393804
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2027-05-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.